PLP1 and paraplegia: In humans, impaired trafficking of PLP due to mutation or altered dosage of the Plp1 gene, causes Pelizaeus-Merzbacher disease (PMD) and Spastic Paraplegia Type 2 (SPG2), developmental disorders with severe neurological impairment (Inoue, 2005).